Massachusetts General Laws
Chapter 94c - Controlled Substances Act
Section 7 - Registration of Persons Who Manufacture, Distribute, Dispense or Possess Controlled Substances

[See Order of the Commissioner of Public Health, dated April 1, 2020, (2019 MA EO H20-18) related to the COVID-19 State of Emergency, for potential impact on the terms of this section.]
Section 7. (a) Except in the case of a pharmacy, wholesale druggist or outsourcing facility, every person who manufactures, distributes or dispenses, or possesses with intent to manufacture, distribute or dispense any controlled substance within the commonwealth shall upon payment of a fee, the amount of which shall be determined annually by the commissioner of administration under the provision of section three B of chapter seven, register with the commissioner of public health, in accordance with his regulations, said registration to be effective for one year from the date of issuance or until completion of the term of the registrant's license issued pursuant to chapter 112, whichever occurs later. Every wholesale druggist and outsourcing facility shall register with the board of registration in pharmacy in accordance with its regulations. Such registration shall be effective until July first, nineteen hundred and seventy-four, if such registration is issued prior to July first, nineteen hundred and seventy-four. Such registration shall be effective until January first, nineteen hundred and seventy-six, if such registration is issued between July first, nineteen hundred and seventy-four, and January first, nineteen hundred and seventy-six. Such registration shall be effective until the end of the calendar year in which said registration is issued if registration is issued subsequent to December thirty-first, nineteen hundred and seventy-five; provided, that such wholesale druggist or outsourcing facility shall pay a registration fee of twenty-five dollars for any initial registration issued prior to July first, nineteen hundred and seventy-four, and shall pay any registration fee of thirty-seven dollars and fifty cents for a registration which is issued between July first, nineteen hundred and seventy-four, and January first, nineteen hundred and seventy-six. Such wholesale druggist or outsourcing facility shall, commencing January first, nineteen hundred and seventy-six, pay an annual registration fee, the amount of which shall be determined by the commissioner of administration, for each year or any part thereof. For the purposes of this section, ''wholesale druggist'' shall mean any person who distributes controlled substances at wholesale. Every pharmacy shall register with the said board in accordance with its regulations. Such registration shall be effective until July first, nineteen hundred and seventy-four, if any registration is issued prior to July first, nineteen hundred and seventy-four. Such registration shall be effective until January first, nineteen hundred and seventy-six, if such registration is issued between July first, nineteen hundred and seventy-four, and January first, nineteen hundred and seventy-six. Such registration shall be effective until the end of the first uneven numbered year following the date of issuance of such registration if such registration is issued subsequent to December thirty-first, nineteen hundred and seventy-five; provided, that such pharmacy shall pay a registration fee of twenty-five dollars for an initial registration issued prior to midnight of July first, nineteen hundred and seventy-four, and shall pay a registration fee of thirty-seven dollars and fifty cents for any registration issued between July first, nineteen hundred and seventy-four, and January first, nineteen hundred and seventy-six, and shall, commencing January first, nineteen hundred and seventy-six, pay a biennial registration fee, the amount of which shall be determined by the commissioner of administration, for every two years, or any part thereof.
(b) Every person who is engaged in the qualitative or quantitative analysis of controlled substances within a scientific laboratory shall, upon payment of a fee, as determined annually by the commissioner of administration under the provision of section three B of chapter seven obtain a registration issued by the commissioner in accordance with his rules, said registration to be effective for one year from date of issuance.
(c) A person registered under this chapter to manufacture, distribute, dispense, or possess controlled substances may possess, manufacture, distribute, or dispense those substances to the extent authorized by his registration and in conformity with the other provisions of this chapter.
(d) The following persons shall not require registration and may lawfully possess and distribute controlled substances:
(1) an agent or employee of any manufacturer, distributor, or dispenser registered under this chapter, if he is acting in the usual course of his business or employment, except that a salesman, detail man or other field representative of a registered manufacturer, wholesaler, jobber or dealer in controlled substances may not possess any controlled substance in schedule I, II, III, IV, or V of section three for the purpose of demonstrating, displaying, selling, or distributing as samples said controlled substances to a practitioner;
(2) a common or contract carrier or warehouseman, or an employee thereof, whose possession of any controlled substance is in the usual course of business or employment;
(3) any public official or law enforcement officer acting in the regular performance of his official duties.
(4) a registered nurse or licensed practical nurse or a licensed dental hygienist under the supervision of a practitioner as defined in section 1 for the purposes of administering local anesthesia agents only when acting under the supervision of a practitioner;
(5) a graduate of a school for nurses or practical nurses which has been approved in accordance with the provisions of chapter one hundred and twelve, whenever said person is acting under the supervision of a practitioner and is engaged in professional practice during the period from such person's graduation from said school until the announcement of the results of the first licensing examination for registered nurses or licensed practical nurses, as the case may be, thereafter held in accordance with the provisions of said chapter one hundred and twelve;
(6) any person duly licensed to practice nursing within any other jurisdiction, whenever such person is acting under the supervision of a practitioner and is discharging official duties as an employee of the federal government;
(7) any person covered by clauses (1), (2), (3) and (5) of section eighty B of chapter one hundred and twelve when any such person is acting under the supervision of a practitioner;
(8) any therapist, technician, or medical student when performing under the supervision of a practitioner those services which are defined to be functions of their respective callings;
(9) any person who belongs to a class of persons which is authorized by regulation of the commissioner to provide services for the purpose of diagnosis, care, treatment, or research.
(10) a duly licensed optometrist who utilizes diagnostic pharmaceutical agents, as defined in section sixty-six A of chapter one hundred and twelve, and who qualifies to utilize such agents for the purpose of conducting an examination of the eye as provided in sections sixty-six A and sixty-eight A of chapter one hundred and twelve; provided, however, that a wholesale distributor or pharmacist may dispense such diagnostic pharmaceutical agents to a licensed optometrist for subsequent administration to optometry patients only if such optometrist provides the wholesale distributor or pharmacist with the number of the optometrist's certification of qualification to administer such diagnostic pharmaceutical agents.
(e) An ultimate user or research subject may lawfully possess or administer a controlled substance at the direction of a practitioner in the course of his professional practice.
(f) Notwithstanding any other provision of this section, the commissioner shall, upon receipt of the fee as hereinbefore provided, automatically issue to any physician, dentist, podiatrist, nurse practitioner, nurse anesthetist, psychiatric nurse mental health clinical specialist or veterinarian who is duly authorized to practice his profession in the commonwealth a registration to dispense, other than for research pursuant to section eight, unless the registration of such physician, dentist, podiatrist, nurse practitioner, nurse anesthetist, psychiatric nurse mental health clinical specialist, or veterinarian has been suspended or revoked pursuant to the provisions of sections thirteen or fourteen or unless said registration is denied for cause by the commissioner pursuant to the provisions of chapter thirty A. Such registration shall continue in full force and effect unless it is suspended or revoked, or unless it is recalled and a new registration issued in accordance with the rules and regulations of the commissioner.
(g) The commissioner may by regulation authorize the registration for a specific activity or activities requiring registration under this section of such persons as he determines to be qualified for such registration.
The commissioner shall promulgate regulations which provide for the registration of certified nurse-midwives, as provided in section 80C of chapter 112, to issue written prescriptions in accordance with regulations under said section 80G of said chapter 112. Prior to promulgating such regulations, the commissioner shall consult with the board of registration in nursing and the board of registration in medicine with regard to those schedules of controlled substances for which certified nurse-midwives may be registered.
The commissioner shall promulgate regulations which provide for the registration of physicians assistants to issue written prescriptions for patients pursuant to guidelines mutually developed and agreed upon by the supervising physician and the physician assistant. Prior to promulgating such regulations, the commissioner shall consult with the board of registration of physician assistants, the board of registration in medicine and the board of registration in pharmacy with regard to those schedules of controlled substances for which physician assistants may be registered to issue written prescriptions therefor; provided, however, that a physician assistant who has not successfully passed the national certification examination for physician assistants or who does not meet all of the current requirements for obtaining an initial physician assistant's registration as listed in section nine I of chapter one hundred and twelve may not be authorized to write prescriptions under any circumstances.
The commissioner shall issue regulations authorizing pharmacists, who have been duly registered in accordance with section 24.5 of chapter 112, to engage in collaborative drug therapy management and to issue written prescriptions in accordance with the provisions of said section 24.5 of said chapter 112 and guidelines mutually developed and agreed upon by the supervising physician and the pharmacist in a collaborative practice agreement, as defined in section 24.5 of said chapter 112, established in accordance with regulations of the board of registration in medicine and board of registration in pharmacy. Prior to issuing such regulations, the commissioner shall consult with the board of registration in medicine and the board of registration in pharmacy with regard to the schedules of controlled substances for which a pharmacist may be authorized to prescribe within the scope of his collaborative practice.
The commissioner may gather patient outcome and cost-savings data if available from objective sources and review community retail drug business-based collaborative drug therapy management. If the commissioner finds that sufficient data and funding sources exist to conduct a valid study, he shall conduct a study within 2 years after that finding. The study shall include representatives of the board of registration in medicine and the board of registration in pharmacy. In conducting the study, the commissioner shall hold at least 1 public hearing to receive testimony from the public, including representatives of pharmacy and medicine and other concerned parties.
(h) The commissioner shall promulgate regulations which provide for the automatic registration of optometrists, upon the receipt of the fee as herein provided, to issue written prescriptions in accordance with the provisions of sections 66, 66B and 66C of chapter 112, unless the registration of such optometrist has been suspended or revoked pursuant to the provisions of section 13 or section 14 or unless such registration is denied for cause by the commissioner pursuant to the provisions of chapter 30A. Prior to promulgating such regulations, the commissioner shall consult with the board of registration in optometry.
(i) Every person who: (i) is in the business of manufacturing or distributing any controlled substances, and (ii) has a principal place of business located in the commonwealth but at no time takes physical possession of any controlled substances, shall register with the commissioner in accordance with the regulations of the department. The registration shall require the payment of a fee, the amount of which shall be determined annually pursuant to section 3B of chapter 7. The registration shall be effective for 1 year from the date of issuance.

Structure Massachusetts General Laws

Massachusetts General Laws

Part I - Administration of the Government

Title XV - Regulation of Trade

Chapter 94c - Controlled Substances Act

Section 1 - Definitions

Section 2 - Establishment of Schedules of Drugs or Other Controlled Substances

Section 2a - Temporary Placement of Substance in Schedule I

Section 3 - Findings Required for Placement in Schedules

Section 4 - Exceptions From Schedules

Section 5 - Dispensing Controlled Substances Excepted Under Sec. 4

Section 6 - Rules and Regulations

Section 6a - Licensure of Certain Corporate Entities With Patients Receiving Opioid Agonist Therapy; Best Practice Guidance for Practitioners

Section 7 - Registration of Persons Who Manufacture, Distribute, Dispense or Possess Controlled Substances

Section 7a - Registration as Participant in Prescription Monitoring Program

Section 8 - Research Projects and Studies

Section 9 - Administering and Dispensing of Controlled Substances in Course of Professional Practice; Records, Inspection

Section 10 - Separate Registration

Section 11 - Inspection of Establishments of Registrants or Applicants

Section 12 - Issuance of Registration to Manufacture or Distribute Controlled Substances

Section 13 - Suspension or Revocation of Registration; Report of Criminal Violations; Controlled Substances Affected Placed Under Embargo; Forfeiture; Notice to Bureau

Section 14 - Suspension of or Refusal to Renew Registration Pending Proceedings in Cases of Imminent Danger to Public

Section 15 - Record-Keeping and Inventory Requirements; Filing of Dea Form 106 With City, Town and State Police Departments Upon Discovery of Theft or Loss of Controlled Substance

Section 16 - Distribution Between Registrants; Order Form

Section 17 - Necessity of Prescription for Dispensing Controlled Substances

Section 18 - Issuance of Prescription by Practitioner or Physician

Section 18a - Prerequisites for Issuing Outpatient Extended-Release Long-Acting Opioid in a Non-Abuse Deterring Form; Written Pain Management Treatment Plan for Long-Term Pain Management

Section 18b - Voluntary Non-Opiate Directive Form

Section 18c - Patient Education Required Before Issuance of Opioid Prescription

Section 19 - Prescription; Restrictions on Issuance

Section 19a - Emergency Contraception

Section 19b - Dispensing, Possessing and Administrating Opioid Antagonist

Section 19b1/2 - Exchange of Naloxone or Other Opioid Antagonist Between Registered Entities

Section 19c - High Opiate Overdose Area Pharmacies Required to Maintain Continuous Supply of Naloxone Rescue Kits or Opioid Antagonist Medications

Section 19d - Supply Limitations for Opiate Prescriptions; Exception for Palliative Care

Section 20 - Oral Prescriptions

Section 20a - Radiopharmaceutical Drugs

Section 21 - Packaging and Labeling by Pharmacist Filling Prescription; Distribution of Educational Pamphlet

Section 21a - Prescriptions; Prospective Drug Review and Counseling by Pharmacist

Section 21b - Advertisement and Sale of Prescription Lock Boxes by Pharmacies

Section 22 - Contents of Prescription Written by Practitioner

Section 23 - Written or Electronic Prescriptions; Requirements and Restrictions

Section 24 - Dispensing by Practitioner for Narcotic Drug Research or Treatment of Drug Dependent Persons

Section 24a - Electronic Monitoring of the Prescribing and Dispensing of Controlled Substances and Certain Additional Drugs

Section 24b - Mean and Median Quantity and Volume of Prescriptions for Opiates; Notification of Practitioner's Own Percentile Ranking

Section 25 - Restrictions

Section 26 - Distribution in Course of Business in Violation of Sec. 16 or Furnishing False Information in Application, etc., Prohibited

Section 27 - Sale of Hypodermic Syringes or Hypodermic Needles

Section 27a - Collection and Disposal of Spent Non-Commercially Generated Hypodermic Needles and Lancets

Section 28 - Jurisdiction of Superior Court

Section 29 - Educational Programs for Prevention of Abuse of Controlled Substances

Section 30 - Administrative Inspection of Controlled Premises

Section 31 - Classes of Controlled Substances; Establishment of Criminal Penalties for Violations of This Chapter

Section 32 - Class a Controlled Substances; Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, etc.; Eligibility for Parole

Section 32a - Class B Controlled Substances; Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, Etc.

Section 32b - Class C Controlled Substances; Unlawful Manufacturer, Distribution, Dispensing or Possession With Intent to Manufacture, Etc.

Section 32c - Class D Controlled Substances; Unlawful Manufacture, Distribution, Dispensing, Cultivation or Possession With Intent to Manufacture, Etc.

Section 32d - Class E Controlled Substances; Unlawful Manufacture, Distribution, Dispensing, or Possession With Intent to Manufacture, Etc.

Section 32e - Trafficking in Marihuana, Cocaine, Heroin, Synthetic Opioids, Morphine, Opium, etc.; Eligibility for Parole

Section 32f - Unlawful Manufacture, Distribution, Dispensing or Possession With Intent to Manufacture, Etc. of Controlled Substances in Classes a to C to Minors

Section 32g - Counterfeit Substances; Unlawful Creation, Distribution, Dispensing or Possession With Intent to Distribute or Dispense

Section 32h - Prosecutions Not to Be Continued or Placed on File; Suspension or Reduction of Sentence; Eligibility for Parole, Etc.

Section 32h1/2 - Good Behavior Deductions From Sentence After Serving Mandatory Minimum Term of Imprisonment; Eligibility; Parole; Work Release

Section 32i - Drug Paraphernalia; Sale, Possession or Manufacture With Intent to Sell; Penalty; Sale of Tobacco Rolling Papers

Section 32j - Controlled Substances Violations In, on or Near School Property or Public Parks or Playgrounds

Section 32k - Inducing or Abetting Minor to Distribute or Sell Controlled Substances

Section 32l - Possession of 2 Ounces or Less of Marihuana; Civil Penalty and Forfeiture; Other Sanctions or Disqualifications Prohibited

Section 32m - Possession of 2 Ounces or Less of Marihuana; Drug Awareness Program

Section 32n - Possession of One Ounce or Less of Marihuana; Enforcement Consistent With Non-Criminal Disposition Provisions of Sec. 21d of Chapter 40; Duty of Police Department; Notice; Failure to File Certificate of Completion of Drug Awareness Prog...

Section 33 - Unlawful Use of Registration Numbers in Manufacture or Distribution, or Fraudulently Obtaining Possession, of Controlled Substances; Criminal Penalties

Section 34 - Unlawful Possession of Particular Controlled Substances, Including Heroin and Marijuana; Lawful Possessing, Storing, Analyzing, Processing and Testing of Medical Marijuana and Medical Marijuana-Infused Products by Laboratories Exception

Section 34a - Immunity From Prosecution Under Sec. 34 or Finding of Violation of Condition of Probation, Pretrial Release or Parole for Persons Seeking Medical Assistance for Self or Other Experiencing Drug-Related Overdose

Section 36 - Protective Custody of Children Found Present Where Controlled Substances Are Unlawfully Kept or Possessed

Section 37 - Theft of Controlled Substances From Persons Authorized to Dispense or Possess

Section 38 - Violation of Secs. 24(a), 25, 26 or 27

Section 39 - Violation of Secs. 21 or 22

Section 40 - Conspiracy

Section 41 - Arrest Without Warrant

Section 42 - Cooperation With Federal and Other State Agencies

Section 43 - Conformity With Federal Acts

Section 44 - Violations of Sec. 34; Acquittal, Dismissal or Indictment Nol Prossed; Sealing of Records

Section 45 - Photographing and Fingerprinting of Persons Charged With Felony

Section 47 - Forfeiture of Property

Section 47a - Seized Controlled Substances and Narcotic Drugs; Custodian; Mailing for Chemical Analysis; Destruction or Disposal Upon Completion of Trial

Section 48 - Severability

Section 49 - Enforcement of Sec. 24a